NCT03728673View on ClinicalTrials.gov

A Study Utilizing Escitalopram in Glioma Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 6, 2019

Primary Completion Date

December 31, 2026

Study Completion Date

August 31, 2027

Conditions
Glioma of BrainGlioma
Interventions
DRUG

Escitalopram Oral Capsules

Active capsules will contain 10 mg escitalopram oxalate.

Trial Locations (1)

68198

RECRUITING

University of Nebraska Medical Center, Omaha

All Listed Sponsors
lead

University of Nebraska

OTHER